Class II Restoration Using Bioactive Restorative Material vs Polyacid Modified Composite Resin in Primary Molars
NCT ID: NCT04030117
Last Updated: 2019-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2019-09-30
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In an attempt to achieve this idealism, a new class of restorative materials known as "bioactive materials" has been developed. The concept of bioactive materials was introduced in 1969 and later defined as "one that elicits a specific biological response at the interface of the material which results in the formation of a bond between tissues and the material." An example of bioactive materials is ACTIVA™ BioACTIVE (Pulpdent, USA). These materials are ionic composite resins which combine the biocompatibility, chemical bond and the ability to release fluoride of glass ionomers with the mechanical properties, esthetic and durability of composite resins.
Compomer is widely accepted as a standard restorative material for primary dentition for Class I and II cavities. Its range of success rate in Class II restorations in primary molars is 78-96%. Many randomized clinical trials have reported comparable clinical performance to composite resin with respect to color matching, marginal discoloration, anatomical form, marginal integrity and secondary caries. In comparison to glass ionomer and Resin Modified Glass Ionomer, compomers tend to have better physical properties in the primary dentition. However, their cariostatic properties didn't differ significantly from those materials.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Alkasite-based Restorations in Children
NCT07263555
Clinical Performance and Psychological Impact of Colored Restorations Cement in Primary Molars
NCT05557682
Endocrown Restoring First Permanent Molar in Children
NCT06432049
Clinical and Radiographic Evaluation of Injectable Composite Versus Packable Composite in Restoring of Primary Molars
NCT07239154
Effectiveness of ART and Conventional Treatment - Practice-based Clinical Trial
NCT02568917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The null hypothesis is that there is no difference between using ACTIVA and Dyract® in children to restore Class II cavities in carious vital primary second molars.
2. Trial design:
* A pilot study, parallel group, two arm.
* Allocation ratio is 1:1.
3. Method
Intervention:
A) Diagnosis:
* Diagnostic chart will be filled with personal, medical and dental history.
* The intra-oral examination will be made using gloves, mask, gauze and dental mirror.
* A pre-operative radiograph (bitewing) will be taken for diagnosis. b) The intervention in this pilot study will be (ACTIVA™ BioACTIVE, Pulpdent, USA) - Gp1 while the comparator will be (Dyract® DENTSPLY, Germany)- Gp2.
Three follow up visits for restoration at:
T1 (3 months), T2 (6 months) and T3 (12 months).
Same procedure in both groups will be followed:
1. The tooth will be anesthetized using local anesthesia, and isolated using rubber dam.
2. Caries will be removed.
3. A proximal box is prepared.
4. A metal matrix band is fixed around the tooth and a wedge is placed interdentally.
5. The restorative material chosen according to the randomization is placed in the cavity according to the manufacturer's instructions.
6. A post-operative digital bitewing radiograph will be taken immediately after the treatment as a base line reference and to check for voids or any defect in the restoration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACTIVA Test arm
Treatment of decay in Class II second primary molars using ACTIVA restorative material.
ACTIVA Bioactive restoration
Removal of Class II decay in second primary molars and placement of ACTIVA restoration.
Compomer Comparator arm
Treatment of decay in Class II second primary molars using compomer restorative material.
Compomer restoration
Removal of Class II decay in second primary molars and placement of Compomer restoration.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACTIVA Bioactive restoration
Removal of Class II decay in second primary molars and placement of ACTIVA restoration.
Compomer restoration
Removal of Class II decay in second primary molars and placement of Compomer restoration.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Proximal enamel/dentin caries limited to outer half of dentin.
3. Age ranging from 4-8 years.
4. Good general health.
Exclusion Criteria
2. Abscess or fistula on examination or during history taking.
3. Tooth mobility.
4. Radiographic evidence of root resorption or close shedding time.
5. Lack of patient co-operation.
4 Years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reem Mohsen Ahmed Moustafa
Assistant Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cairo University
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19121987
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.